BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32912170)

  • 41. CVE: an R package for interactive variant prioritisation in precision oncology.
    Mock A; Murphy S; Morris J; Marass F; Rosenfeld N; Massie C
    BMC Med Genomics; 2017 May; 10(1):37. PubMed ID: 28545463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic lymphocytic leukaemia genomics and the precision medicine era.
    Ghamlouch H; Nguyen-Khac F; Bernard OA
    Br J Haematol; 2017 Sep; 178(6):852-870. PubMed ID: 28444740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review.
    Fatkin D; Huttner IG; Kovacic JC; Seidman JG; Seidman CE
    J Am Coll Cardiol; 2019 Dec; 74(23):2921-2938. PubMed ID: 31806137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leveraging Genomic Factors to Improve Benefit-Risk.
    Schuck RN; Charlab R; Blumenthal GM
    Clin Transl Sci; 2017 Mar; 10(2):78-83. PubMed ID: 28160443
    [No Abstract]   [Full Text] [Related]  

  • 45. NOJAH: NOt Just Another Heatmap for genome-wide cluster analysis.
    Rupji M; Dwivedi B; Kowalski J
    PLoS One; 2019; 14(3):e0204542. PubMed ID: 30921318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
    Wilson BJ; Miller FA; Rousseau F
    J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GenomeQC: a quality assessment tool for genome assemblies and gene structure annotations.
    Manchanda N; Portwood JL; Woodhouse MR; Seetharam AS; Lawrence-Dill CJ; Andorf CM; Hufford MB
    BMC Genomics; 2020 Mar; 21(1):193. PubMed ID: 32122303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Required Human and System Resources for Genomic Medicine].
    Aimono E; Nishihara H
    Yakugaku Zasshi; 2020; 140(5):651-655. PubMed ID: 32378666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
    Damodaran S; Berger MF; Roychowdhury S
    Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of RNA Sequencing Data Using CLC Genomics Workbench.
    Liu CH; Di YP
    Methods Mol Biol; 2020; 2102():61-113. PubMed ID: 31989550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer.
    Fraser M; Berlin A; Bristow RG; van der Kwast T
    Urol Oncol; 2015 Feb; 33(2):85-94. PubMed ID: 24768356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overview of the development of personalized genomic medicine and surgery.
    Brunicardi FC; Gibbs RA; Wheeler DA; Nemunaitis J; Fisher W; Goss J; Chen C
    World J Surg; 2011 Aug; 35(8):1693-9. PubMed ID: 21424870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome analysis and knowledge-driven variant interpretation with TGex.
    Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
    BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
    Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
    Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics data.
    Lee S; Sun M; Hu Y; Wang Y; Islam MN; Goerlitz D; Lucas PC; Lee AV; Swain SM; Tang G; Wang XS
    BMC Bioinformatics; 2024 Jun; 25(1):220. PubMed ID: 38898383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer Target Gene Screening: a web application for breast cancer target gene screening using multi-omics data analysis.
    Kim HY; Choi HJ; Lee JY; Kong G
    Brief Bioinform; 2020 Mar; 21(2):663-675. PubMed ID: 30698638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomics to personalize care of prostate cancer.
    Connors LM
    J Am Assoc Nurse Pract; 2020 Feb; 32(2):106-108. PubMed ID: 32015276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FungiExpresZ: an intuitive package for fungal gene expression data analysis, visualization and discovery.
    Parsania C; Chen R; Sethiya P; Miao Z; Dong L; Wong KH
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36806894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.